Low response to a monovalent inactivated unadjuvanted influenza A (H1N1) pdm09 vaccine in pediatricians of a general hospital in Japan

References

• Hanquet G, Van Damme P, Brasseur D, De Cuyper X, Gregor S, Holmberg M, et al. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine 2011; 29:370 - 7; http://dx.doi.org/10.1016/j.vaccine.2010.10.079; PMID: 21075164
   PubMed Web of Science ®Google Scholar
• Amodio E, Anastasi G, Marsala MG, Torregrossa MV, Romano N, Firenze A. Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy). Vaccine 2011; 29:1408 - 12; http://dx.doi.org/10.1016/j.vaccine.2010.12.041; PMID: 21199700
   PubMed Web of Science ®Google Scholar
• Tanguy M, Boyeau C, Pean S, Marijon E, Delhumeau A, Fanello S. Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a french teaching hospital. Vaccine 2011; 29:4190 - 4; http://dx.doi.org/10.1016/j.vaccine.2011.03.107; PMID: 21497636
   PubMed Web of Science ®Google Scholar
• Ortqvist A, Berggren I, Insulander M, de Jong B, Svenungsson B. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Clin Infect Dis 2011; 52:1203 - 11; http://dx.doi.org/10.1093/cid/cir182; PMID: 21507917
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among health-care personnel --- United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep 2011; 60:1073 - 7; PMID: 21849963
   PubMedGoogle Scholar
• Bernstein HH, Starke JR, American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement--recommendation for mandatory influenza immunization of all health care personnel. Pediatrics 2010; 126:809 - 15; http://dx.doi.org/10.1542/peds.2010-2376; PMID: 20837587
   PubMed Web of Science ®Google Scholar
• Okada T, Morozumi M, Matsubara K, Komiyama O, Ubukata K, Takahashi T, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother 2011; 17:238 - 45; http://dx.doi.org/10.1007/s10156-010-0115-z; PMID: 20827563
   PubMed Web of Science ®Google Scholar
• Sugaya N, Shinjoh M, Mitamura K, Takahashi T. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children. J Infect 2011; 63:288 - 94; http://dx.doi.org/10.1016/j.jinf.2011.06.008; PMID: 21722665
   PubMed Web of Science ®Google Scholar
• De Witte E, Goossens H, Ieven M. Evaluation of the ESPLINE® Influenza A & B-N assay for the detection of influenza A and B in nasopharyngeal aspirates. Eur J Clin Microbiol Infect Dis 2011; In press PMID: 21953031
   PubMed Web of Science ®Google Scholar
• Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405 - 13; http://dx.doi.org/10.1056/NEJMoa0907413; PMID: 19745216
   PubMed Web of Science ®Google Scholar
• (CPMP). ECfPMP. Note for guidance on harmonisation of requirements for influenza vaccines. In: (EMEA) EAftEoMP, ed. London, UK: Committee for Proprietary Medicinal Products (CPMP), 2007.
   Google Scholar
• Ministry of Health L, Welfare A Phase II Randomized Clinical Trial of a monovalent, inactivated, unadjuvanted influenza A (H1N1) 2009 in healthcare personnel., 2009.
   Google Scholar
• Igari H, Segawa S, Watanabe A, Suzuki A, Watanabe M, Sakurai T, et al. Immunogenicity of a monovalent pandemic influenza A H1N1 vaccine in health-care workers of a university hospital in Japan. Microbiol Immunol 2010; 54:618 - 24; PMID: 21118299
   PubMed Web of Science ®Google Scholar
• Zhan Y, Yang Z, Li L, Ye D, Wu H, Fu R, et al. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China. Jpn J Infect Dis 2011; 64:190 - 4; PMID: 21617301
   PubMed Web of Science ®Google Scholar
• Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 2004; 173:673 - 81; PMID: 15210831
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176:6333 - 9; PMID: 16670345
   PubMed Web of Science ®Google Scholar
• Uno S, Kimachi K, Kei J, Miyazaki K, Oohama A, Nishimura T, et al. Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial. Microbiol Immunol 2011; 55:783 - 9; http://dx.doi.org/10.1111/j.1348-0421.2011.00381.x; PMID: 21895745
   PubMed Web of Science ®Google Scholar
• Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010; 33:492 - 503; http://dx.doi.org/10.1016/j.immuni.2010.10.002; PMID: 21029960
   PubMed Web of Science ®Google Scholar
• Ikematsu H, Nagai H, Kawashima M, Kawakami Y, Tenjinbaru K, Maeda A, et al. Immunogenicity and safety of a novel AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan. Hum Vaccin 2010; 6:888 - 93; http://dx.doi.org/10.4161/hv.6.11.12851; PMID: 19806020
   PubMed Web of Science ®Google Scholar
• Madhun AS, Akselsen PE, Sjursen H, Pedersen G, Svindland S, Nøstbakken JK, et al. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 2010; 29:266 - 73; http://dx.doi.org/10.1016/j.vaccine.2010.10.038; PMID: 21034828
   PubMed Web of Science ®Google Scholar
• Halperin W, Weiss WI, Altman R, Diamond MA, Black KJ, Iaci AW, et al. A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature. Am J Public Health 1979; 69:1247 - 51; http://dx.doi.org/10.2105/AJPH.69.12.1247; PMID: 507256
   PubMed Web of Science ®Google Scholar
• Society JP. Request document for intramuscular injection. 2011.
   Google Scholar
• Plotkin SA. Vaccines. Saunders; (February 7, 2008), 2008.
   Google Scholar
• Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004; 351:2295 - 301; http://dx.doi.org/10.1056/NEJMoa043540; PMID: 15525714
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, et al. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Vaccine 2008; 26:6614 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.09.078; PMID: 18930093
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008; 198:650 - 8; http://dx.doi.org/10.1086/590434; PMID: 18652550
   PubMed Web of Science ®Google Scholar
• Kis EE, Winter G, Myschik J. Devices for intradermal vaccination. Vaccine 2012; 30:523 - 38; http://dx.doi.org/10.1016/j.vaccine.2011.11.020; PMID: 22100637
   PubMed Web of Science ®Google Scholar